Education
About Us
Working with TipRanks
Follow Us
Windtree Therapeutics (WINT)
OTHER OTC:WINT
Total Valuation
Windtree Therapeutics has a market cap or net worth of $582.15K. The enterprise value is $13.27M.
Market Cap$582.15K
Enterprise Value$13.27M
Share Statistics
Windtree Therapeutics has 33,708,782 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,708,782
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Windtree Therapeutics’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -107.25%.
Return on Equity (ROE)-0.55
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-107.25%
Return on Capital Employed (ROCE)-1.13
Revenue Per Employee0.00
Profits Per Employee-127.64K
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Windtree Therapeutics is ―. Windtree Therapeutics’s PEG ratio is 0.00171.
PE Ratio―
PS Ratio0.00
PB Ratio0.09
Price to Fair Value0.09
Price to FCF-0.06
Price to Operating Cash Flow>-0.01
PEG Ratio0.00171
Income Statement
In the last 12 months, Windtree Therapeutics had revenue of 0.00 and earned -5.49M in profits. Earnings per share was -104.35.
Revenue0.00
Gross Profit-84.00K
Operating Income-25.02M
Pretax Income-1.79M
Net Income-5.49M
EBITDA-1.47M
Earnings Per Share (EPS)-104.35
Cash Flow
In the last 12 months, operating cash flow was -15.12M and capital expenditures 0.00, giving a free cash flow of -15.12M billion.
Operating Cash Flow-15.12M
Free Cash Flow-15.12M
Free Cash Flow per Share-0.45
Dividends & Yields
Windtree Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change-99.73%
50-Day Moving Average0.04
200-Day Moving Average0.38
Relative Strength Index (RSI)17.84
Average Volume (3m)403.29K
Important Dates
Windtree Therapeutics upcoming earnings date is Apr 8, 2026, TBA (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateApr 8, 2026
Ex-Dividend Date―
Financial Position
Windtree Therapeutics as a current ratio of 0.45, with Debt / Equity ratio of -111.35%
Current Ratio0.45
Quick Ratio0.45
Debt to Market Cap0.72
Net Debt to EBITDA-0.03
Interest Coverage Ratio-106.46
Taxes
In the past 12 months, Windtree Therapeutics has paid 3.69M in taxes.
Income Tax3.69M
Effective Tax Rate-2.06
Enterprise Valuation
Windtree Therapeutics EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.06.
EV to Sales0.00
EV to EBITDA-0.65
EV to Free Cash Flow-0.06
EV to Operating Cash Flow-0.06
Balance Sheet
Windtree Therapeutics has $204.00K in cash and marketable securities with $12.93M in debt, giving a net cash position of -$12.72M billion.
Cash & Marketable Securities$204.00K
Total Debt$12.93M
Net Cash-$12.72M
Net Cash Per Share-$0.38
Tangible Book Value Per Share-$268.79
Margins
Gross margin is 12.22%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin12.22%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Windtree Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast99.09%